WASHINGTON (Reuters) - Watson Pharmaceuticals has won U.S. antitrust approval to buy Swiss peer Actavis Inc on the condition that it sell a number of their current and future products to two other companies, the Federal Trade Commission said on Monday.
via Reuters: Health News Read More Here..
No comments:
Post a Comment